18
Aug
2010
20
Jul
2010
11
Jun
2010
14
May
2010
12
May
2010
Astute Medical, Inc.: Series B $26.5M
Posted in I - Series B, Q - 2Q10, R - WEST, X - Device (Diagnostic), X - Pain, X - Sepsis, XX - CA
Astute Medical (San Diego, CA) a development-stage diagnostic company focused on the identification and validation of protein biomarkers that can test for hospital acquired acute conditions like sepsis, kidney injury and abdominal pain, closed a $26.5M Series B financing. Participants include Domain Associates, Delphi Ventures, Johnson & Johnson Development Corp. and De Novo Ventures.
16
Apr
2010
Achaogen, Inc. : Series C $56M
Posted in I - Series C, Q - 2Q10, R - WEST, X - Antibacterial, X - MDR, XX - CA
Achaogen (San Francisco, CA) a clinical-stage a biopharmaceutical company focused on the discovery and development of broad-spectrum antibiotics to treat life-threatening, multi-drug resistant bacterial infections, closed a $56M Series C financing. Participants include Frazier Healthcare Ventures, Alta Partners, 5 AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and Wellcome Trust.
14
Apr
2010
Tragara Pharmaceuticals, Inc.: Series B $5M
Posted in I - Series B, Q - 1Q10, R - WEST, X - Inflammation, X - Oncology, X - Pain, XX - CA
Tragara Pharmaceuticals (San Diego, CA) a clinical-stage biopharmaceutical company focused on selective biomarker for oncology, pain and inflammation therapeutics, closed a $5M Series B financing. Participants include Domain Associates, Mitsubishi Corp., Morgethaler Ventures, Oxford Bioscience Partners and ProQuest Investments.
30
Mar
2010
17
Mar
2010
Syndax Pharmaceuticals, Inc.: Series A $9M
Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - HDAC, X - Oncology, XX - MA
Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.
16
Mar
2010
Syndax Pharmaceuticals, Inc.: Series A $9M
Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - HDAC, X - Oncology, XX - MA
Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.
02
Mar
2010
Tandem Diabetes Care, Inc.: Series C $30.8M
Posted in I - Series C, Q - 1Q10, R - WEST, X - Device (Diabetes), X - Device (Pump), XX - CA
Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participants include HLM Venture Partners, Domain Associates, TPG Biotech, Delphi Ventures and Kearny Venture Partners.
08
Feb
2010
Zogenix, Inc.: Series B $20M
Posted in I - Series B, Q - 4Q09, R - WEST, X - Device (Delivery), X - Drug:Device Combo, XX - CA
Zogenix (San Diego, CA) a clinical-stage drug:device company focused on a needle-free delivery system of chronic pain therapeutics, closed a $20M Series B financing, bringing the total round to $71M. Participants have included Chicago Growth Partners, Clarus Ventures, Domain Associates, Scale Venture Partners, Thomas McNerney & Partners, Oxford Finance and Abingworth Management.
Note: 2009 Year-in-Review Trend [...]
08
Feb
2010
Apnex Medical, Inc.: Series B $14M
Posted in I - Series B, Q - 4Q09, R - MID WEST, X - Device (Sleep Apnea), XX - MN
Apnex Medical (St. Paul, MN) a clinical-stage medical device company developing an implantable treatment for moderate-to-severe obstructive sleep apnea, closed a $14M Series B financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
OnBioVC PARTNERS
-
